Paper · 39158595
New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities.
Yue YY and 6 others. J Mol Med (Berl), 2024. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities. Papers, record 39158595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39158595
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Fibroblast Growth Factor, Type 2 | Major topic |
| Craniofacial Dysostosis | Major topic |
| Disease Models, Animal | Major topic |
| CRISPR-Cas Systems | Major topic |
| Skull | Major topic |
| Animals | |
| Mice | |
| Phenotype | |
| Behavior, Animal | |
| Gene Editing | |
| Male | |
| Female |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,417,861 | Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis. | Cell | 2021 | https://conductscience.org/library/papers/33417861 | PubMed |
| 2 | 29,236,889 | Syndromic craniosynostosis: neuropsycholinguistic abilities and imaging analysis of the central nervous system. | Arq Neuropsiquiatr | 2017 | https://conductscience.org/library/papers/29236889 | PubMed |
| 3 | 21,248,745 | Craniosynostosis. | Eur J Hum Genet | 2011 | https://conductscience.org/library/papers/21248745 | PubMed |
| 4 | 38,369,396 | Association of cranial base suture/synchondrosis fusion with severity of increased intracranial pressure in Crouzon syndrome. | J Craniomaxillofac Surg | 2024 | https://conductscience.org/library/papers/38369396 | PubMed |
| 5 | 20,643,727 | Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. | Pediatrics | 2010 | https://conductscience.org/library/papers/20643727 | PubMed |
| 6 | 14,499,350 | A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. | Bone | 2003 | https://conductscience.org/library/papers/14499350 | PubMed |
| 7 | 20,503,384 | The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling. | Dev Dyn | 2010 | https://conductscience.org/library/papers/20503384 | PubMed |
| 8 | 20,077,479 | Brain phenotypes in two FGFR2 mouse models for Apert syndrome. | Dev Dyn | 2010 | https://conductscience.org/library/papers/20077479 | PubMed |
| 9 | 35,254,402 | FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model. | J Exp Med | 2022 | https://conductscience.org/library/papers/35254402 | PubMed |
| 10 | 30,633,021 | Analysis of Airway and Midface in Crouzon Syndromes. | Ann Plast Surg | 2019 | https://conductscience.org/library/papers/30633021 | PubMed |
1 to 10 of 46
See all 46 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,615,907 | Fzd7 Restrains Pink1-Dependent Mitophagy in Suture Stem Cells to Maintain Cranial Suture Patency. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42615907 | PubMed |
| 42,258,016 | Mitochondria-related gene and protein changes in craniosynostosis: integrated transcriptomics and Fgfr2C361Y/+ cranial suture proteomics. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42258016 | PubMed |
| 42,071,254 | Spatiotemporal single-cell atlas of suture stem cell dynamics in craniosynostosis. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42071254 | PubMed |
| 41,768,990 | Human cranial stem cells: developmental, pathologic, and therapeutic implications. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41768990 | PubMed |
| 41,584,352 | Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584352 | PubMed |
| 41,390,905 | P38α MAPK-induced senescence in cranial suture progenitor cells promotes craniosynostosis. | Commun Biol | 2025 | https://conductscience.org/library/papers/41390905 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39158595
GET https://conductscience.org/api/papers/v1/39158595/references?page=2